Amgen Reveals First Figures For US Humira Rival

Q1 Sales Disclosed For Amjevita Biosimilar As Brand Loses A Quarter Of Value In US

Apr 28 2023

• By David Wallace

Amgen has published Q1 financial results for its US Humira biosimilar • Source: Shutterstock

More from Earnings

More from Business